Metabolic abnormalities and use of HIV-1 protease inhibitors
Authors:
- Esteban MartinezEMEsteban Martinez
- José GatellJGJosé Gatell
- 1 September 1998
- journal article
- other
- Published by Elsevier in The Lancet
- Vol. 352 (9130) , 821-822
Abstract
No abstract availableThis publication has 5 references indexed in Scilit:
- Pathogenesis of HIV-1-protease inhibitor-associated peripheral lipodystrophy, hyperlipidaemia, and insulin resistanceThe Lancet, 1998
- Not all fat is alikeThe Lancet, 1998
- Does central obesity reflect “Cushing's disease of the omentum”?The Lancet, 1997
- A cumulative specificity model for proteases from human immunodeficiency virus types 1 and 2, inferred from statistical analysis of an extended substrate data baseJournal of Biological Chemistry, 1991
- Production of insulin resistance by hyperinsulinaemia in manDiabetologia, 1985